#BEGIN_DRUGCARD DB01971

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
104-98-3

# ChEBI_ID:
30817

# Chemical_Formula:
C6H6N2O2

# Chemical_IUPAC_Name:
(2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
1500 mg/L (at 17 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
trans-urocanic acid

# HET_ID:
URO

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/b2-1+

# InChI_Key:
InChIKey=LOIYMIARKYCTBW-OWOJBTEDSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00785

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1971

# Mechanism_Of_Action:
Not Available

# Melting_Point:
225 °C

# Molecular_Weight_Avg:
138.124

# Molecular_Weight_Mono:
138.042927446

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1W1U

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.22

# Predicted_LogS:
-0.51

# Predicted_Water_Solubility:
4.25e+01 g/l

# Primary_Accession_No:
DB01971

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03207

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)\C=C\C1=CNC=N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
(2E)-3-(1H-imidazol-4-yl)acrylic acid
(E)-3-(1H-imidazol-4-yl)-2-propenoic acid
Urocanic acid

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:40 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE015451

# Drug_Target_1_GenBank_ID_Protein:
24986811

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hutU

# Drug_Target_1_Gene_Sequence:
>1674 bp
TCAGCCGGTGATCATCGGCAGGTCCAGGCCCTGCTCCTTGGCGCAGTCGATGGCGATGTC
ATAACCGGCATCGGCGTGACGCATGACGCCAGTCCCTGGGTCGTTGGTCAGTACCCGGGC
GATGCGCTCGGCGGCCTCATCGGTACCGTCGCAGACGATGACCATGCCCGAGTGCTGCGA
GAAGCCCATGCCCACGCCACCGCCATGGTGCAGCGATACCCAGGTGGCGCCGCCTGCGGT
GTTCAGCAGGGCGTTGAGCAGCGGCCAGTCGGAAACAGCGTCCGAACCATCACGCATGGC
CTCGGTTTCGCGGTTCGGGCTGGATACCGAGCCGGAGTCGAGGTGGTCACGGCCGATCAC
CACCGGTGCCGACAGCTCGCCGCTGCGGACCATTTCGTTGAAAGCCAGGCCCAGCTTGGC
GCGAAGGCCCAGCCCCACCCAGCAGATACGTGCCGGCAGGCCCTGGAAGCTGATGCGCTC
GCGGGCCATGTCCAGCCAGCGGTGCAGGTGGGCGTCGTCGGGGATCAGTTCCTTGACCTT
GGCGTCGGTCTTGTAGATGTCCTCGGCTTCACCGGACAGCGCCGCCCAGCGGAACGGGCC
GACGCCGCGGCAGAACAGTGGGCGGATGTAGGCCGGGACGAAGCCTGGGAAGTCGAAGGC
ATTGGCCACGCCCTCCTCCTTGGCCATCTGGCGGATGTTGTTGCCGTAATCGAAGGTCGG
GATGCCCTGCTTCTGGAAGTCCAGCATGGCCTGCACGTGCACGGCCATCGACTGCTTGGC
GGCCTTGACCACTGCAGCCGGTTCGGTCTGCGCACGATCGCGGTACTGTTCCCAGGTCCA
GCCGGCTGGCAGGTAGCCGTTCAGTGGGTCGTGGGCGCTGGTCTGGTCGGTGACCATGTC
CGGGCGGACGCCACGTTTGACCAGCTCTGGGAGGATTTCGGCGGCGTTGCCGTGCAGGGC
GATGGAGATGGCCTTGCCTTCGGCGGTGTACTTGGCGATGCGTGCGAGGGCGTCGTCGAG
GTCAGTGGCCTGCTCGTCGACGTAGCGGGTTTCCAGGCGGAAGTCGATACGGCTCTGCTG
GCATTCGATGTTCAGCGAGCAAGCCCCAGCCAGGGTCGCGGCCAGTGGCTGGGCGCCGCC
CATGCCGCCCAGGCCAGCGGTGAGTACCCACTTGCCTTTCAGGCTGCCGCCGTAGTGCTG
GCGACCGGCTTCGACGAAGGTTTCATAGGTGCCCTGGACGATGCCCTGGCTGCCGATGTA
GATCCAGCTGCCGGCGGTCATCTGGCCATACATCGCCAGGCCCTTGGCGTCCAGTTCGTT
GAAGTGTTCCCAGTTGGCCCAGTGTGGCACCAGGTTGGAGTTGGCAATCAGCACGCGCGG
TGCGTTGCTGTGGGTCTTGAACACACCGACCGGCTTGCCCGACTGCACCAGCAGGGTTTC
GTCGTCTTCCAGGCGGGTCAGGGTTTCGACGATCTTGTCGTAGCAGGCCCAGTTGCGCGC
GGCGCGGCCGATACCGCCGTATACCACCAGCTCTTTCGGGTTTTCCGCGACCTGTGGATC
GAGGTTGTTCATCAGCATGCGCAGTGGCGCTTCGGTCAGCCAGCTTTTGGCGGTCAGCTT
GTTGCCACGTGGGGCACGGATTTCAACGTCACGGTATTTGTTGTTGTCGGTCAC

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
12534463	Nelson KE, Weinel C, Paulsen IT, Dodson RJ, Hilbert H, Martins dos Santos VA, Fouts DE, Gill SR, Pop M, Holmes M, Brinkac L, Beanan M, DeBoy RT, Daugherty S, Kolonay J, Madupu R, Nelson W, White O, Peterson J, Khouri H, Hance I, Chris Lee P, Holtzapple E, Scanlan D, Tran K, Moazzez A, Utterback T, Rizzo M, Lee K, Kosack D, Moestl D, Wedler H, Lauber J, Stjepandic D, Hoheisel J, Straetz M, Heim S, Kiewitz C, Eisen JA, Timmis KN, Dusterhoft A, Tummler B, Fraser CM: Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol. 2002 Dec;4(12):799-808.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2591

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
60718

# Drug_Target_1_Name:
Urocanate hydratase

# Drug_Target_1_Number_of_Residues:
557

# Drug_Target_1_PDB_ID:
1UWL

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01175	Urocanase

# Drug_Target_1_Protein_Sequence:
>Urocanate hydratase
MTDNNKYRDVEIRAPRGNKLTAKSWLTEAPLRMLMNNLDPQVAENPKELVVYGGIGRAAR
NWACYDKIVETLTRLEDDETLLVQSGKPVGVFKTHSNAPRVLIANSNLVPHWANWEHFNE
LDAKGLAMYGQMTAGSWIYIGSQGIVQGTYETFVEAGRQHYGGSLKGKWVLTAGLGGMGG
AQPLAATLAGACSLNIECQQSRIDFRLETRYVDEQATDLDDALARIAKYTAEGKAISIAL
HGNAAEILPELVKRGVRPDMVTDQTSAHDPLNGYLPAGWTWEQYRDRAQTEPAAVVKAAK
QSMAVHVQAMLDFQKQGIPTFDYGNNIRQMAKEEGVANAFDFPGFVPAYIRPLFCRGVGP
FRWAALSGEAEDIYKTDAKVKELIPDDAHLHRWLDMARERISFQGLPARICWVGLGLRAK
LGLAFNEMVRSGELSAPVVIGRDHLDSGSVSSPNRETEAMRDGSDAVSDWPLLNALLNTA
GGATWVSLHHGGGVGMGFSQHSGMVIVCDGTDEAAERIARVLTNDPGTGVMRHADAGYDI
AIDCAKEQGLDLPMITG

# Drug_Target_1_Reaction:
3-(5-oxo-4,5-dihydro-3H-imidazol-4-yl)propanoate = urocanate + H2O

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
3-(5-oxo-4,5-dihydro-3H-imidazol-4- yl)propanoate = urocanate + H(2)O

# Drug_Target_1_SwissProt_ID:
Q88CZ6

# Drug_Target_1_SwissProt_Name:
HUTU_PSEPK

# Drug_Target_1_Synonyms:
EC 4.2.1.49
Imidazolonepropionate hydrolase
Urocanase

# Drug_Target_1_Theoretical_pI:
5.76

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01971
